These data indicate a potential “dual synergy” in which GPR‐120 and HDL‐C exert complementary protective effects, whereas high LDL‐C or triglycerides could disrupt that synergy, accelerating kidney injury. This evidence concerns the gene FFAR4 and medical procedure.